Delivery Order SPE2DX15D1053-CM58
- Not listed
- This federal contract award is a delivery order valued at $578,388.00 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of August 4, 2015. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $177,231.85, is a delivery order for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract is Firm Fixed Price with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for a delivery order with a ceiling value of $110,080.42, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a Prime Vendor pharmaceutical support role serving the Philadelphia region, with an ultimate completion date of May 25, 2016. It is a firm fixed-price contract and was not set aside for any specific business category....
- This federal contract award, valued at $140,251.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the prime vendor pharmaceutical branch in Philadelphia, with a firm fixed price pricing type. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $117,046.48, is for a prime vendor pharmaceutical branch in Philadelphia. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $86,589.18 Firm Fixed Price Delivery Order contract is for a Prime Vendor Pharmacy Branch in Philadelphia and has an ultimate completion date of September 2, 2016. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for a delivery order with a ceiling value of $115,107.96, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a "Prime Vendor Pharm Branch-Philadelphia" and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $93,111.91 Firm Fixed Price delivery order contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of August 3, 2017. The contract is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.86 firm fixed-price delivery order contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $111,936.41 firm fixed price delivery order is for a Prime Vendor Pharmacy Branch in Philadelphia, with an ultimate completion date of April 29, 2015. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DX15D1053Indefinite Delivery Contract
- SPE2DX15D1053-CM58Delivery Order
This federal contract award, with a value of $114,989.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of September 9, 2016. It is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $115.0k | 9/9/16 |